Iovance Biotherapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Iovance Biotherapeutics, Inc. (IOVA) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.120.110.470.080.070.310.47
Short-Term Investments0.210.160.240.430.560.000.00
Cash & Short-Term Investments0.320.280.470.500.630.310.47
Accounts Receivable0.070.000.000.000.000.000.00
Inventory0.050.010.000.000.000.000.00
Other Current Assets0.010.020.020.000.010.010.00
Total Current Assets0.460.310.480.510.640.320.48
Non-Current Assets
Property, Plant & Equipment (Net)0.160.180.180.170.110.020.00
Long-Term Investments0.000.000.000.090.000.000.00
Intangible Assets0.280.230.000.000.000.000.00
Other Non-Current Assets0.010.070.000.010.020.000.00
Total Non-Current Assets0.450.470.180.270.130.020.01
Total Assets0.910.780.660.780.770.340.48
Current Liabilities
Accounts Payable0.030.030.080.030.010.030.01
Short-Term Debt0.030.000.000.000.000.000.00
Accrued Liabilities0.080.070.050.060.030.000.00
Other Current Liabilities0.010.000.010.000.00-0.200.00
Total Current Liabilities0.120.110.090.090.050.040.01
Non-Current Liabilities
Long-Term Debt0.000.000.070.000.050.000.00
Deferred Tax Liabilities0.030.020.000.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.010.010.00
Total Non-Current Liabilities0.080.090.070.070.060.010.00
Total Liabilities0.200.200.160.160.110.050.01
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-2.38-2.01-1.57-1.17-0.83-0.57-0.37
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital3.102.592.071.791.490.870.84
Shares Outstanding0.310.260.190.160.000.000.00
Total Stockholders' Equity0.710.580.500.620.660.000.47
Total Liabilities & Equity0.910.780.660.780.770.340.48